FAQ on the New High Blood Pressure Guideline for Prevention and Early Treatment

What is the main focus of the new high blood pressure guideline?

The guideline focuses on the prevention and early treatment of high blood pressure to reduce the risk of cardiovascular disease, including heart attack, stroke, and heart failure, through lifestyle modifications and medications as needed.

Why is this new guideline important?

It’s important because nearly half of all adults in the U.S. have high blood pressure, which is the #1 preventable risk factor for cardiovascular disease, and the guideline provides updated recommendations based on the latest scientific evidence.

How does the guideline recommend managing high blood pressure?

The guideline recommends managing high blood pressure through healthy lifestyle behaviors, such as eating a nutritious diet, being physically active, maintaining a healthy weight, and using medications if necessary, along with close monitoring and the use of the PREVENT™ risk calculator.

Who is affected by this new guideline?

Adults in the U.S. with high blood pressure, especially those at risk for cardiovascular disease, as well as healthcare providers who manage and treat high blood pressure, are affected by this guideline.

When does this guideline take effect?

The guideline was published on August 14, 2025, and replaces the 2017 guideline, with its recommendations taking effect upon publication.

What are the key changes in this guideline compared to the 2017 version?

Key changes include earlier treatment recommendations, the emphasis on lifestyle modification, the introduction of the PREVENT™ risk calculator for tailored treatment, and specific recommendations for managing blood pressure before, during, and after pregnancy.

What should people know or do about this guideline?

People should be aware of their blood pressure levels, adopt healthy lifestyle behaviors, and consult healthcare providers for early treatment if diagnosed with high blood pressure to reduce cardiovascular disease risk.

Who developed and endorsed this guideline?

The guideline was developed by the American Heart Association and American College of Cardiology Joint Committee on Clinical Practice Guidelines, in collaboration with and endorsed by 11 other healthcare organizations.